PHAT - Balance Sheet - Phathom Pharmaceuticals, Inc.

Current Liabilities	85.7 M
Accounts Payable	10.5 M
Short-Term Debt	1 M
Other Current Liabilities	74.2 M
Non-Current Liabilities	546 M
Long-Term Debt	0
Other Non-Current Liabilities	546 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	297.3	381.4	155.4	183.3	287.5	243.8	0.9
Short Term Investments	0	0	0	0	0	0	0
Receivables	38.8	1.6	0	0	82 K	0	0
Inventory	3.2	1.2	0	0	82 K	0	0
Other Current Assets	20.9	13.2	10.3	6.5	7.7	23.7	4 K
Total Current Assets	360.1	397.4	160.5	186.5	291.4	255.6	0.9
PP&E	2.1	3.6	3.5	2.6	3.4	1.4	0
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	0	0	0.5	0	0	0	0
Other Long Term Assets	16.1	12.8	0.3	0.3	0.4	0.2	0
Other Assets	0	0	0	0	0	0	0
Total Assets	378.3	413.8	164.8	189.4	295.1	257.2	0.9
LIABILITIES
Accounts Payable	10.5	12.6	10.0	5.2	16.8	0.7	55 K
Short Term Debt	1.0	0.7	1.4	1.0	8.3	0.3	1.9
Other Current Liabilities	74.2	25.5	14.8	12.8	30.4	2.7	0.2
Total Current Liabilities	85.7	38.8	26.2	18.9	55.5	3.7	2.2
Long Term Debt	0	138.3	96.4	90.9	41.2	23.4	0
Deferred Tax Income	0	0	0	0	0	0	0
Other Liabilities	546.2	309.5	117.0	7.5	4.1	2.1	0
Total Liabilities	631.9	486.6	239.6	117.3	100.8	29.2	2.2
EQUITY
Common Stock	6 K	5 K	3 K	3 K	3 K	2 K	0
Retained Earnings	(1 263.0)	(928.7)	(727.1)	(529.4)	(385.5)	(256.4)	(1.3)
Other Accumulative Comprehensive Income/Loss	0	0	0	0	0	0	0
Total Equity	(253.6)	(72.8)	(74.8)	72.2	194.3	228.0	(1.3)
Total Liabilities and Equity	378.3	413.8	164.8	189.4	295.1	257.2	0.9
SHARES OUTSTANDING
Common Shares Outstanding	63.2	51.3	39.1	37.0	33.2	24.7	8.6

Free